Molecular Oncology - Diagnostic Lab in Union, New Jersey

Expertise in the diagnosis of cancer and similar diseases

At our laboratory, we specialize in the various stages of cancer diagnosis, including screening, risk prediction, prognosis, monitoring, and therapeutic triage of malignancies, all aimed at reducing the number of cancer patients. Our wide use of methodologies in oncology testing procedures, including molecular techniques, FISH, flow cytometry, and immunohistochemistry, enable us to serve various people and practices.

There are more than 100 types of cancer. Types of cancer are usually named for the organs or tissues where the cancers form, but they also may be described by the type of cell that formed them:

Common Cancer Types:

Breast cancer
Cervical cancer
Colorectal cancer
Leukemia
Liver cancer
Lung cancer
Lymphoma
Melanoma
Multiple myeloma
Myeloproliferative neoplasms
Ovarian cancer
Pancreatic cancer
Prostate cancer
Testicular cancer
Thyroid cancer

All Cancer Types »

Traditional Cancer Markers:

Alpha-Fetoprotein (AFP) Blood
Cancer Antigen CA 125
Cancer Antigen CA 15-3
Cancer Antigen CA 19-9
Cancer Antigen CA 27.29
CEA (Carcinoembryonic Antigen)
Prostate Health Index (phi)
Prostate-Specific Antigen PSA
Prostate-Specific Antigen Free: Total Ratio
Prostatic Acid Phosphatase (Male PAP)
Serum Protein Electrophoresis (SPEP)

All Oncology Tests

Test Name

17-Ketosteroids, Urine
1p/19q Deletion by FISH
5’Nucleotidase, Serum
5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 5 Mutations
5-Hydroxyindoleacetic Acid (HIAA), Urine
Acid Hemolysin (Ham Test)Paroxysmal Nocturnal Hemoglobinuria (PNH)
Acute Lymphocytic Leukemia (ALL) Panel by FISH, Adult
Acute Lymphocytic Leukemia (ALL) Panel by FISH, Pediatric
Acute Myelogenous Leukemia (AML) with Myelodysplastic Syndrome (MDS), or Therapy-Related AML, by FISH
Acute Myelogenous Leukemia Panel by FISH
Adrenocorticotropic Hormone (ACTH) by Immunohistochemistry
Adrenocorticotropic Hormone, Plasma
Pan Cytokeratin (AE1,3) by Immunohistochemistry
Aggressive B-Cell Lymphoma FISH Reflex, Tissue
ALK (D5F3) by Immunohistochemistry with Reflex to ALK Gene Rearrangements by FISH
ALK (D5F3) with Interpretation by Immunohistochemistry
ALK Gene Rearrangements in NSCLC for Crizotinib Eligibility by FISH
Alkaline Phosphatase Isoenzymes, Serum or Plasma
Alkaline Phosphatase, Serum or Plasma
Alpha Fetoprotein, Plasma or Serum (Tumor Marker)
Alpha Fetoprotein, Total and L3 Percent
Alpha-1-Antichymotrypsin (A1ACT) by Immunohistochemistry
Alpha-1-Fetoprotein (AFP) by Immunohistochemistry
Anaplastic Lymphoma Kinase 1 (ALK-1) by Immunohistochemistry
Angiotensin Converting Enzyme, Serum
Arginase 1 by Immunohistochemistry
Arginine Vasopressin Hormone, Plasma
B Cell Specific Octamer Binding Protein-1 (BOB-1) by Immunohistochemistry
B-Cell CD20 Expression
B-Cell Clonality Screening (IgH and IgK) by PCR
BCL-2 by Immunohistochemistry
BCL-6 by Immunohistochemistry
BCR-ABL1 Mutation Analysis by Next Generation Sequencing
BCR-ABL1, Major (p210), Quantitative
BCR-ABL1, Minor (p190), Quantitative
BCR-ABL1, Qualitative with Reflex to BCR-ABL1 Quantitative
Bence Jones Protein, Qualitative Free Kappa and Lambda Light Chains, Urine
Bence Jones Protein, Quantitative Free Kappa and Lambda Light Chains, Urine
Anti-Human Epithelial Antigen, Ber-EP4 by Immunohistochemistry
Beta-2 Microglobulin, Serum or Plasma
Beta-Catenin-1 by Immunohistochemistry
Beta-hCG, Serum Quantitative (Tumor Marker)
BF-1 by Immunohistochemistry
Bladder Tumor Associated Antigen
Bone Marrow Failure Sequencing, 35 Genes
Bone Marrow, Chromosome Analysis with Reflex to Genomic Microarray
Bone Specific Alkaline Phosphatase, Serum
BRAF codon 600 Mutation Detection by Pyrosequencing
BRAF Codon 600 Mutation Detection with Reflex to MLH1 Promoter Methylation
BRAF V600E Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
BRAF V600E Mutation Detection in Hairy Cell Leukemia by Real-Time PCR, Quantitative
Breast 2 (GCDFP-15) by Immunohistochemistry
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 20 Genes
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing and Deletion/Duplication
Breast Carcinoma b72.3 by Immunohistochemistry
c-MET by Immunohistochemistry
C-MYC by Immunohistochemistry
C-Peptide, Serum or Plasma
Calcitonin by Immunohistochemistry
Calcitonin, Serum or Plasma
Caldesmon by Immunohistochemistry
CALR (Calreticulin) Exon 9 Mutation Analysis by PCR
Calretinin by Immunohistochemistry
Cancer Antigen 125 by Immunohistochemistry
Cancer Antigen 125, Serum or Plasma
Cancer Antigen 27.29, Serum
Cancer Antigen-Breast (CA 15-3), Serum or Plasma
Cancer Antigen-GI (CA 19-9), Body Fluid
Cancer Antigen-GI (CA 19-9), Serum or Plasma
Cancer Panel, Hereditary, Deletion/Duplication, 46 Genes
Cancer Panel, Hereditary, Sequencing and Deletion/Duplication, 47 Genes
Carcinoembryonic Antigen, Fluid
Carcinoembryonic Antigen, Monoclonal (CEA M) by Immunohistochemistry
Carcinoembryonic Antigen, Polyclonal (CEA P) by Immunohistochemistry
Carcinoembryonic Antigen, Serum
Carotenes, Fractionated, Plasma or Serum
Catecholamines Fractionated by LC-MS/MS, Urine Free
Catecholamines Fractionated, Plasma
CBFB-MYH11 inv(16) Detection, Quantitative
CD10 (CALLA) by Immunohistochemistry
CD117 (c-Kit) by Immunohistochemistry
CD138 (Syndecan-1) by Immunohistochemistry
CD14 by Immunohistochemistry
CD15, Leu M1 by Immunohistochemistry
CD19 by Immunohistochemistry
CD1a by Immunohistochemistry
CD2 by Immunohistochemistry
CD20, L26 by Immunohistochemistry
CD21 (Dendritic Cell) by Immunohistochemistry
CD23 by Immunohistochemistry
CD25 by Immunohistochemistry
CD3 by Immunohistochemistry
CD30 (Ki-1) by Immunohistochemistry
CD33 by Immunohistochemistry
CD34, QBEnd/10 by Immunohistochemistry
CD35 by Immunohistochemistry
CD4 by Immunohistochemistry
CD42b by Immunohistochemistry
CD43, L60 (Leu 22) by Immunohistochemistry
CD44 by Immunohistochemistry
CD45 by Immunohistochemistry
CD5 by Immunohistochemistry
CD52 (CAMPATH-1) by Immunohistochemistry
CD56 (NCAM) by Immunohistochemistry
CD57 by Immunohistochemistry
CD61 (Platelet Glycoprotein IIIA) by Immunohistochemistry
CD68, KP1 by Immunohistochemistry
CD7 by Immunohistochemistry
CD79A by Immunohistochemistry
CD8 by Immunohistochemistry
CDK4 by Immunohistochemistry
CDX2 by Immunohistochemistry
CEBPA Mutation Detection
Central Nervous System Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes
Chromogranin A by Immunohistochemistry
Chromogranin A, Serum
Chromosome Analysis, Bone Marrow
Chromosome Analysis, Leukemic Blood
Chromosome Analysis, Peripheral Blood
Chromosome Analysis, Solid Tumor
Chromosome FISH, CLL Panel
Chromosome FISH, Interphase
Chromosome FISH, Multiple Myeloma Panel Process and Hold
Circulating Tumor Cell Count
Colon Cancer Gene Panel, Somatic
Creatine Kinase Isoenzymes, Serum
CXCL13 by Immunohistochemistry
Cyclic AMP, Urine
Cyclin D1, SP4 by Immunohistochemistry
Cytochrome P450 2C19, CYP2C19 – 9 Variants
Cytochrome P450 2C9, CYP2C9 – 2 Variants
Cytochrome P450 2D6 (CYP2D6) 14 Mutations and Gene Duplication
Cytochrome P450 Genotype Panel
Cytogenomic Molecular Inversion Probe Array, Copy Number and Heterozygosity Assessment – Formalin-Fixed Paraffin-Embedded (FFPE) Tissue
Cytogenomic SNP Microarray—Oncology
Cytokeratin 19 (CK 19) by Immunohistochemistry
Cytokeratin 19 Fragment (CYFRA 21-1), Serum
Cytokeratin 20 (CK 20) by Immunohistochemistry
Cytokeratin 5,6 (CK 5,6) by Immunohistochemistry
Cytokeratin 7 (CK 7) by Immunohistochemistry
Cytokeratin 8,18 Low Molecular Weight (CAM 5.2) by Immunohistochemistry
Cytokine Panel 12 by MAFD, Serum or Plasma
Cytology, Fine Needle Aspirate
Cytology, Non-Gynecologic
Cytology, SurePath Liquid-Based Pap
Cytology, SurePath Liquid-Based Pap Test and Human Papillomavirus (HPV), High Risk by Hybrid Capture (for routine co-testing in women over 30)
Cytology, SurePath Liquid-Based Pap Test with Reflex to Human Papillomavirus (HPV) DNA Probe, High Risk
Cytology, ThinPrep Pap Test and Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
Cytology, ThinPrep® Pap Test
Cytology, ThinPrep® Pap Test with Reflex to Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
Cytomegalovirus Antibody, IgG, Serum
D2-40 by Immunohistochemistry
DDIT3 (CHOP) (12q13) Gene Rearrangement by FISH
Dehydroepiandrosterone Sulfate, Serum or Plasma
Des-gamma-carboxy Prothrombin, Serum
Desmin by Immunohistochemistry
Dihydropyrimidine Dehydrogenase (DPYD) Genotyping, 3 Mutations
DNA Content/Cell Cycle Analysis, Miscellaneous
DOG1 by Immunohistochemistry
E-Cadherin by Immunohistochemistry
EGFR by FISH
EGFR Mutation Detection by Pyrosequencing
EGFR T790M Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
EIF2AK4-Associated Disorders (EIF2AK4) Sequencing
Endocrine Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 13 Genes
Eosinophilia Panel by FISH
Epi proColon
Epithelial Membrane Antigen (EMA) by Immunohistochemistry
Epithelial-related Antigen, MOC-31 by Immunohistochemistry
Epstein-Barr Virus (EBV) by in situ Hybridization, Paraffin
Epstein-Barr Virus, Quantitative PCR
ERBB2 (HER-2/neu) Gene Amplification by FISH, Tissue
ERBB2 (HER2)(HercepTest) by Immunohistochemistry
ERBB2 (HercepTest®) by Immunohistochemistry, Tissue with Reflex to FISH if 2+
ERBB2 (HercepTest®) with Interpretation by Immunohistochemistry, Tissue
Erythropietin, Serum or Plasma
Esterase Stain, Nonspecific
Estradiol, Serum, Adult Premenopausal Female, Serum or Plasma
Estrogen Receptor (ER) by Immunohistochemistry
Estrogen/Progesterone Receptor with Interpretation by Immunohistochemistry
Ewing Sarcoma (O13) by Immunohistochemistry
EWSR1 (22q12) Gene Rearrangement by FISH
Factor XIIIa by Immunohistochemistry
Familial Adenomatous Polyposis (APC) Sequencing
Familial Adenomatous Polyposis Panel: APC Sequencing, APC Deletion/Duplication, and MYH 2 Mutations
Familial Mutation, Targeted Sequencing
FLT3 Mutation Detection by PCR
FLT3 Signal Ratio Mutation Detection by PCR
Follicle Stimulating Hormone, Serum
FOXO1 (FKHR) (13q14) Gene Rearrangement by FISH
Friend Leukemia Integration-1 (Fli-1) by Immunohistochemistry
Gastrin by Immunohistochemistry
Gastrin, Serum
Gastrointestinal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 16 Genes
Gastrointestinal Stromal Tumor Mutation
Glial Fibrillary Acidic Protein (GFAP) by Immunohistochemistry
Glucagon, Plasma
Glucose-6-Phosphate Dehydrogenase
Glypican 3 by Immunohistochemistry
Granzyme B by Immunohistochemistry
Growth Hormone, Serum or Plasma
HBME-1 (Mesothelial Cell) by Immunohistochemistry
Helicobacter pylori by Immunohistochemistry
Hepatocellular Carcinoma Tumor Marker Panel
Hepatocyte Specific Antigen (HSA) by Immunohistochemistry
HER-2/neu Quantitative by ELISA
Hereditary Paraganglioma-Pheochromocytoma (SDHB) Sequencing and Deletion/Duplication
Hereditary Paraganglioma-Pheochromocytoma (SDHB, SDHC, and SDHD) Deletion/Duplication
Hereditary Paraganglioma-Pheochromocytoma (SDHB, SDHC, and SDHD) Sequencing and Deletion/Duplication Panel
Hereditary Paraganglioma-Pheochromocytoma (SDHC) Sequencing and Deletion/Duplication
Hereditary Paraganglioma-Pheochromocytoma (SDHD) Sequencing and Deletion/Duplication
Herpes Virus 8 by Immunohistochemistry
HLA-B*5701 Associated Variant Genotyping for Abacavir Sensitivity
Melanoma Antibody, HMB45 by Immunohistochemistry
HNPCC/Lynch Syndrome (MLH1) Sequencing and Deletion/Duplication
HNPCC/Lynch Syndrome (MSH2) Sequencing and Deletion/Duplication
HNPCC/Lynch Syndrome (MSH6) Sequencing and Deletion/Duplication
HNPCC/Lynch Syndrome (PMS2) Sequencing and Deletion/Duplication
HNPCC/Lynch Syndrome Deletion/Duplication
Homovanillic Acid (HVA), Urine
HRAS Mutation Detection by Pyrosequencing
Human Chorionic Gonadotropin (Beta-hCG) by Immunohistochemistry
Human Epididymis Protein 4 (HE4)
Growth Hormone by Immunohistochemistry
Human Papillomavirus (HPV) 16 and 18 Genotype by PCR, SurePath
Human Papillomavirus (HPV) DNA Probe, High Risk, Cervical Brush
Human Papillomavirus (HPV) Genotypes 16 and 18/45, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
Human Papillomavirus (HPV) High Risk In Situ Hybridization, Paraffin
Human Papillomavirus (HPV) Low Risk by In Situ Hybridization, Paraffin
Human Papillomavirus (HPV), High Risk by Hybrid Capture (SurePath)
Human Papillomavirus (HPV), High Risk by Hybrid Capture, ThinPrep
Human Papillomavirus (HPV), High Risk by PCR, SurePath
Human Papillomavirus (HPV), High Risk by PCR, ThinPrep
Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, SurePath
Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, ThinPrep
Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA) with Reflex to Genotypes 16 and 18/45
Human Placental Lactogen (HPL) by Immunohistochemistry
Human T-Lymphotrophic Virus Types I/II Antibodies, Western Blot
Human T-Lymphotropic Virus Types I/II Antibodies with Reflex to HTLV I/II Confirmation
IDH1 and IDH2 Mutation Analysis, exon 4
IDH1 R132H Point Mutation with Interpretation by Immunohistochemistry
IDH1R132H Mutation by Immunohistochemistry
IGF-1 (Insulin-Like Growth Factor 1)
IGH-BCL2 Fusion, t(14;18) by FISH for Detection in Follicular Lymphoma
IGH-CCND1 (BCL-1/JH) Translocation, t(11;14) by PCR
IGH-CCND1 Fusion, t(11;14) by FISH
IGH-MYC Fusion t(8;14) by FISH for Detection in Burkitt Lymphoma
IGHV Mutation Analysis by Sequencing
Immunofixation Electrophoresis Gel
Inhibin A (Dimer), Serum
Inhibin B, Serum
Inhibin by Immunohistochemistry
INI1 (BAF47) by Immunohistochemistry
Insulin, Fasting, Serum or Plasma
Interleukin 28 B (IL28B)—Associated Variants, 2SNPs
MUM1/IRF4 by Immunohistochemistry
JAK2 Exon 12 Mutation Analysis by PCR
JAK2 Gene, V617F Mutation, Qualitative
JAK2 Gene, V617F Mutation, Qualitative with Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR with Reflex to MPL codon 515 Mutation Detection by Pyrosequencing, Quantitative
JAK2 Gene, V617F Mutation, Qualitative with Reflex to JAK2 Exon 12 Mutation Analysis by PCR
JAK2 Gene, V617F Mutation, Quantitation
Juvenile Polyposis (BMPR1A) Sequencing
Juvenile Polyposis (SMAD4) Deletion/Duplication
Juvenile Polyposis (SMAD4) Sequencing
Juvenile Polyposis (SMAD4) Sequencing and Deletion/Duplication
Juvenile Polyposis Syndrome (BMPR1A) Deletion/Duplication
Kappa Light Chains by Immunohistochemistry
Kappa/Lambda Quantitative Free Light Chains with Ratio, Serum
Keratin 903 (K903) High Molecular Weight by Immunohistochemistry
Ki-67 with Interpretation by Immunohistochemistry
Ki-67, MIB1, by Immunohistochemistry
KIT Mutations in AML by Fragment Analysis and Sequencing
KIT Mutations, Melanoma
KRAS Mutation Detection
KRAS Mutation Detection with BRAF reflex
Lactate Dehydrogenase, Serum or Plasma
Lambda Light Chains by Immunohistochemistry
Leukemia/Lymphoma Phenotyping by Flow Cytometry
Leukemic Blood, Chromosome Analysis with Reflex to Genomic Microarray
Leukocyte Alkaline Phosphatase
Lipid Associated Sialic Acid, Serum
Lung Cancer Panel
Lung Cancer Panel with KRAS
Luteinizing Hormone, Serum
Lymphoma (Aggressive) Panel by FISH
Lysozyme, Urine
Macroprolactin, Serum or Plasma
Mast Cell Tryptase by Immunohistochemistry
MDM2 by Immunohistochemistry
MDM2 Gene Amplification by FISH
Melan A by Immunohistochemistry
Melanoma Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 6 Genes
MET Gene Amplification by FISH
Metanephrines, Plasma (Free)
Methylenetetrahydrofolate Reductase (MTHFR) 2 Mutations
MGMT Methylation Detection by PCR
Microsatellite Instability (MSI), HNPCC/Lynch Syndrome, by PCR
Mismatch Repair by Immunohistochemistry
Mismatch Repair by Immunohistochemistry with Reflex to BRAF Codon 600 Mutation and MLH1 Promoter Methylation
Mismatch Repair by Immunohistochemistry with Reflex to MLH1 Promoter Methylation
MITF by Immunohistochemistry
MLH1 Promoter Methylation, Paraffin
Molar Pregnancy, 16 DNA Markers
Motor and Sensory Neuropathy Evaluation with Immunofixation Electrophoresis and Reflex to Titer and Neuronal Immunoblot
Motor and Sensory Neuropathy Evaluation with Reflex to Titer and Neuronal Immunoblot
Motor Neuropathy Panel
MPL codon 515 Mutation Detection by Pyrosequencing, Quantitative
Muc-1 by Immunohistochemistry
Muc-4 by Immunohistochemistry
Muc-5AC by Immunohistochemistry
Multiple Endocrine Neoplasia Type 2 (MEN2), RET Gene Mutations by Sequencing
Multiple Myeloma Panel by FISH
Muscle-Specific Actin (MSA) by Immunohistochemistry
MUTYH-Associated Polyposis (MUTYH) 2 Mutations
MYC (8q24) Gene Rearrangement by FISH
MYCN (N-MYC) Gene Amplification by FISH
MYD88 L265P Mutation Detection by PCR, Quantitative
Myelodysplastic Syndrome (MDS) Panel by FISH
Myeloid Malignancies Mutation Panel by Next Generation Sequencing
Myeloid Malignancies Somatic Mutation and Copy Number Analysis Panel
Myeloperoxidase (MPO) by Immunohistochemistry
Myeloproliferative Disorders Panel by FISH
Myogenin (Myf4) by Immunohistochemistry
Myoglobin by Immunohistochemistry
Myosin by Immunohistochemistry
Napsin A by Immunohistochemistry
Neurofilament by Immunohistochemistry
Neuron Specific Enolase, CSF
Neuron Specific Enolase, Polyclonal (NSE P) by Immunohistochemistry
Neuron Specific Enolase, Serum
Neuronal Nuclear (Hu, Ri, Yo, and Amphiphysin) Antibodies IgG by Immunoblot
Neuronal Nuclear Antibodies (ANNA) IgG, Immunoblot, Serum
Neuronal Nuclear Antibody (ANNA) IgG by IFA with Reflex to Titer and Immunoblot,
Neuronal Nuclear Antibody (ANNA) Titer IgG by IFA, Serum
Neuronal Nuclei (NeuN) by Immunohistochemistry
NMP22®
NPM1 Mutation by PCR and Fragment Analysis
NRAS Mutation Detection by Pyrosequencing
Octamer Transcription Factor-2 (Oct 2) by Immunohistochemistry
Octamer Transcription Factor-3 and -4 (Oct 3/4) by Immunohistochemistry
Opioid Receptor, Mu (OPRM1) Genotype, 1 Variant
p16 by Immunohistochemistry
p21 (Waf1/Cip 1) by Immunohistochemistry
P504S (AMACR) by Immunohistochemistry
p53 by Immunohistochemistry
p53 with Interpretation by Immunohistochemistry
p63 by Immunohistochemistry
Pancreatic Polypeptide, Serum
Pancreatitis, (PRSS1) Sequencing
Pancreatobiliary FISH
Parathyroid Hormone (PTH) by Immunohistochemistry
Parathyroid Hormone, Intact with Calcium
Parathyroid Hormone, Intact, Serum or Plasma
Parathyroid Hormone-Related Peptide (PTHrP)
Plasma
Whole Blood
Pax-5 by Immunohistochemistry
PAX8 by Immunohistochemistry
PAX8-PPARG Translocations Detection by PCR
PCA3 – Prostate Cancer Biomarker by Transcription-Mediated Amplification
PD-1 by Immunohistochemistry with Interpretation
PD-L1 22C3 pharmaDx by Immunohistochemistry with Interpretation, pembrolizumab (KEYTRUDA)
PD-L1 28-8 pharmDx by Immunohistochemistry with Interpretation, nivolumab (OPDIVO)
Peutz-Jeghers Syndrome (STK11) Deletion/Duplication
Peutz-Jeghers Syndrome (STK11) Sequencing
Peutz-Jeghers Syndrome (STK11) Sequencing and Deletion/Duplication
PIK3CA Mutation Detection
Placental Alkaline Phosphatase (PLAP) by Immunohistochemistry
PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative
PML/RARα Translocation by FISH
Procollagen Type I Intact N-Terminal Propeptide, Serum
Progesterone Receptor (PR) by Immunohistochemistry
Proinsulin
Proinsulin/Insulin Ratio
Prolactin by Immunohistochemistry
Prolactin Macroadenoma, Serum or Plasma
Prolactin, Serum or Plasma
Prosigna Breast Cancer Prognostic Gene Signature
Prostate Specific Antigen by Immunohistochemistry
Prostate Specific Antigen, Complexed
Prostate Specific Antigen, Free Percentage (includes Free PSA and Total PSA), Serum or Plasma
Prostate Specific Antigen, Total – Medicare Screening
Prostate Specific Antigen, Total with Reflex to Free PSA (includes Free
Prostate Specific Antigen, Total, Serum or Plasma
Prostate Specific Antigen, Ultrasensitive, Serum or Plasma
Prostatic Acid Phosphatase
Prostatic Acid Phosphatase (PAP) by Immunohistochemistry
Protein Electrophoresis with Reflex to Immunofixation Electrophoresis Monoclonal Protein Detection, Quantitation and Characterization, IgA, IgG, & IgM, Serum
Protein Electrophoresis, CSF
Protein Gene Product (PGP) 9.5 by Immunohistochemistry
PTEN by Immunohistochemistry
PTEN with Interpretation by Immunohistochemistry
Purkinje Cell Cytoplasmic Antibody by IFA with Reflex to Titer and Immunoblot, Serum
Raji Cell Immune Complex Assay, Serum
RBC Band 3 Protein Reduction in Hereditary Spherocytosis
Renal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes
RET Gene Rearrangements by FISH
RET-CCDC6 and RET-NCOA4 (RET-PTC1 and RET-PTC3) Translocations Detection by PCR
Risk of Ovarian Malignancy Algorithm
ROS1 by FISH
ROS1 with Interpretation by Immunohistochemistry with Reflex to FISH if Equivocal
RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Detection, Quantitative
S-100 Protein by Immunohistochemistry
S-100B Protein, Serum
SDHB with Interpretation by Immunohistochemistry
Sensory Neuropathy Antibody Panel with Reflex to Titer and Neuronal Western Blot
Serotonin, Serum
Serotonin, Whole Blood
Sezary Cell Exam
Smooth Muscle Actin (SMA) by Immunohistochemistry
Solid Tumor Mutation Panel by Next Generation Sequencing
Soluble Mesothelin Related peptides (MESOMARK®), Serum
Somatostatin, Plasma
Special Stain, Periodic Acid-Schiff (PAS)
Squamous Cell Carcinoma Antigen, Serum
SS18 (SYT) (18q11) Gene Rearrangement by FISH
Synaptophysin by Immunohistochemistry
T-Cell Clonality by Flow Cytometry Analysis of TCR V-Beta
T-Cell Clonality by Next Generation Sequencing
T-Cell Clonality Screening by PCR
T-cell Intracytoplasmic Antigen (TIA-1) by Immunohistochemistry
Tartrate-Resistant Acid Phosphatase (TRAP) by Immunohistochemistry
TdT by Immunohistochemistry
Testosterone, Females or Children
Thiopurine Methyltransferase (TPMT) Genotyping, 4 Variants
Thiopurine Methyltransferase, RBC
Thyroglobulin Antibody
Thyroglobulin by Immunohistochemistry
Thyroglobulin by LC-MS/MS, Serum or Plasma
Thyroglobulin, Fine Needle Aspiration (FNA)
Thyroid Stimulating Hormone, Serum or Plasma
Thyroid Transcription Factor (TTF-1) by Immunohistochemistry
Thyroid Translocation and Mutation Panel
Tumor Necrosis Factor, Alpha, Serum or Plasma
UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping
Ulex Europaeus Agglutinin 1 (UEA-1) by Immunohistochemistry
UroVysion FISH
Vanillylmandelic Acid (VMA) & Homovanillic Acid (HVA), Urine
Vanillylmandelic Acid (VMA), Urine
Vasoactive Intestinal Peptide, Plasma
Vimentin by Immunohistochemistry
Viscosity, Serum
Vitamin D, 1, 25-Dihydroxy, Serum or Plasma
Warfarin Sensitivity, CYP2C9 & VKORC1, 3 Variants
Wilms Tumor (WT1), N-terminus by Immunohistochemistry
WT1 Mutation Detection by Sequencing
ZAP-70 Analysis by Flow Cytometry testing

References:

https://www.cancer.gov/about-cancer/screening/screening-tests